13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 5 managers

Reported value

$258.4M

Holders

5

+0 new · −0 exited

Holders’ est. mark

−$25M

Price effect on 5 books still in the name

Largest holder

$200.5M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC279K$200.5M−$18.2MAdded$55.6M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main52.7K$37.9M−$4.17MAdded$4.68M
Swiss Life Asset Management Ltd18.4K$13.2M−$1.9MCut−$2.89M
Employees Provident Fund Board7.5K$5.39M−$618.8KAdded$459K
Leonteq Securities AG2.07K$1.49M−$159.3KAdded$217.9K

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.